APSF News & Updates
New Guidance Outlines Recommendations for Infection Control in Anesthesiology
December 11, 2018 -A writing panel consisting of experts in anesthesiology and infection prevention has developed new guidance on how hospitals and healthcare providers may reduce infections associated with anesthesiology procedures and equipment…
UPDATE: SRNA Winners Announced! 2018 APSF Trainee Quality Improvement (TQI) Program Award Winners
October 22, 2018 -The APSF Committee on Education and Training, under the direction of APSF leadership, is pleased to announce the 2018 APSF Trainee Quality Improvement (TQI) Program Award Winners. The program hosts…
2019 Investigator Initiated Research (IIR) Grant Recipients
October 18, 2018 -The Anesthesia Patient Safety Foundation (APSF) is pleased to announce the recipients of the 2019 Investigator Initiated Research (IIR) Grants. The program’s objective is to stimulate and fund studies that…
Upcoming APSF Newsletter Articles – October 2018
September 20, 2018 -Read preview summaries of upcoming APSF Newsletter articles featured in the October 2018 issue. (Volume 32, No. 2) Early Warning Systems: ‘Found Dead in Bed’ Should be a Never Event…
APSF Safety Recognition Award Winners – 2018
September 5, 2018 -The Anesthesia Patient Safety Foundation is pleased to announce the Safety Recognition Award Winners for Best Practices for Safe Medication Administration during Anesthesia Care. The Anesthesia Patient Safety Foundation seeks…
New Factor Xa Inhibitor (Xarelto®) (Eliquis®) Reversal Agent
August 5, 2018 -The first Factor Xa inhibitor reversal agent, andexanet alfa (brand name of AndexXa®) received FDA approval in early May 2018. Aandexanet alfa is indicated for patients who have been treated…